
HealthReuterswsjtimes-uk+6der-spiegelmorningstarhvgThe Independentseeking-alphainvesting-com1d ago9 sources
AstraZeneca Halts Lung Cancer Drug Trial
AstraZeneca has discontinued a late-stage clinical trial for its lung cancer drug, volrustomig, following a setback in data review. This decision marks a blow to the pharmaceutical company's pipeline for new treatments.